Evidence map›Paper›PMID 36140623›Full record

ReviewDiagnostics (Basel, Switzerland)2022

Endocytoscopic Observation of Esophageal Lesions: Our Own Experience and a Review of the Literature.

Youichi Kumagai, Kaiyo Takubo, Kenro Kawada, Masayuki Ohue, Morihiro Higashi, Toru Ishiguro, Satoshi Hatano, Yoshitaka Toyomasu, Takatoshi Matsuyama, Erito Mochiki and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Youichi KumagaiDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe 350-8550, Saitama, Japan.
Kaiyo TakuboResearch Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo 173-0015, Japan.
Kenro KawadaDepartment of Esophageal and General Surgery, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Masayuki OhueDepartment of Surgery, Osaka International Cancer Center, Osaka 541-8567, Japan.
Morihiro HigashiDepartment of Pathology, Saitama Medical Center, Saitama Medical University, Saitama 350-0495, Japan.ORCID 0000-0002-0093-8977
Toru IshiguroDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe 350-8550, Saitama, Japan.
Satoshi HatanoDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe 350-8550, Saitama, Japan.
Yoshitaka ToyomasuDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe 350-8550, Saitama, Japan.
Takatoshi MatsuyamaDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe 350-8550, Saitama, Japan.
Erito MochikiDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe 350-8550, Saitama, Japan.
Hideyuki IshidaDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe 350-8550, Saitama, Japan.
Social Insurance Saitama Chuo Hospital · JPOsaka International Cancer Institute · JPTokyo Medical and Dental University · JPTokyo Metropolitan Institute of Gerontology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review outlines the process of the development of the endocytoscope (EC) with reference to previously reported studies including our own. The EC is an ultra-high-magnification endoscope capable of imaging at the cellular level. The esophagus is the most suitable site for EC observation because it is amenable to vital staining. The diagnosis of esophageal lesions using EC is based on nuclear density and nuclear abnormality, allowing biopsy histology to be omitted. The observation of nuclear abnormality requires a magnification of ×600 or higher using digital technology. Several staining methods have been proposed, but single staining with toluidine blue or methylene blue is most suitable because the contrast at the border of a cancerous area can be easily identified. A three-tier classification of esophageal lesions visualized by EC is proposed: Type 1 (non-cancerous), Type 2 (endocytoscopic borderline), and Type 3 (cancerous). Since characteristic EC images reflecting pathology can be obtained from non-cancerous esophageal lesions, a modified form of classification with four additional characteristic non-cancerous EC features has also been proposed. Recently, deep-learning AI for analysis of esophageal EC images has revealed that its diagnostic accuracy is comparable to that of expert pathologists.

Indexed as

artificial intelligenceendocytoscopyesophageal canceresophagitisesophagusvital staining

Identifiers

PMID36140623
PMCPMC9498282
OpenAlexW4295765458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.